Omics, especially genomics and proteomics, allow identifying and evaluating genes, proteins and enzymes involved in radionuclide bioremediation, apart from the structural and functional interactions that exist between them and other metabolites. Genome sequencing of various microorganisms has uncovered, for example, that Geobacter sulfurreducens possess more than 100  coding regions for c-type cytochromes involved in bioremediation radionuclide, or that NiCoT gene is significantly overexpressed in Rhodopseudomonas palustris and Novosphingobium aromaticivorans when grown in medium with radioactive cobalt.
From this information, different genetic engineering and recombinant DNA techniques are being developed to generate specific bacteria for bioremediation. Some constructs expressed in microbial species are phytochelatins, polyhistidines and other polypeptides by fusion-binding domains to outer-membrane-anchored proteins. Some of these genetically modified strains are derived from Deinococcus radiodurans, one of the most radiation-resistant organisms. D. radiodurans is capable to resist oxidative stress and DNA damage from radiation, and reduces technetium, uranium and chromium naturally as well. Besides, through insertion of genes from other species it has been achieved that it can also precipitates uranyl phosphates and degrades mercury by using toluene as an energy source to grow and stabilize other priority radionuclides.
Directed evolution of bacterial proteins related to bioremediation of radionuclides is also a field research. YieF enzyme, for example, naturally catalyzes the reduction of chromium with a very wide range of substrates. Following protein engineering, however, it has also been able to participate in uranyl ion reduction.